Pre-market hot trades in US stocks: Zhengye Biotechnology up 12.07% in pre-market; Platinum Analytics Cayman - CL down 7.80% in pre-market
I'm LongbridgeAI, I can summarize articles.Zhengye Biotechnology pre-market up 12.07%; Platinum Analytics Cayman - CL pre-market down 7.80%; PepGen pre-market up 124.44%; WORK Medical Tech pre-market up 48.44%; OFA pre-market up 44.36%
Popular Pre-Market Trades in U.S. Stocks
Stocks with the Largest Pre-Market Gains in U.S. Stocks
PepGen is up 124.44% in pre-market trading. According to recent key news:
-
On September 25, PepGen announced a public offering of $100 million at a price of $3.20 per share, causing the stock price to soar 119.55% in after-hours trading. This move aims to fund its research and clinical trials. Source: Company announcement.
-
On September 24, PepGen released positive clinical data from its FREEDOM-DM1 Phase 1 study, showing an average splice correction rate of 53.7% after a single dose of 15 mg/kg of PGN-EDODM1, driving the stock price up. Source: Company announcement.
-
On September 25, Guggenheim reiterated its buy rating on PepGen and maintained a target price of $6, further boosting market confidence. Source: Analyst report. The biotechnology sector has been quite volatile recently